Simulation and artificial intelligent methodologies for end-to-end bio-pharmaceutical manufacturing and supply chain risk management
Driven by the critical challenges in the bio-pharmaceutical industry, including complexity, high variability, and lengthy lead time, we create new simulation and artificial intelligent methodologies to improve the end-to-end bioprocess understanding, guide the decision making, facilitate the develop...
| Published: |
|
|---|---|
| Online Access: | http://hdl.handle.net/2047/D20398282 |